Hosted on MSN

Gilead Topples On A Surprise Setback For Its 99.9% Effective HIV Drug

Gilead stock toppled Thursday after CVS HealthCVS said it won't add the company's new HIV prevention drug, Yeztugo, to its commercial plans for now. The decision is based on clinical, financial and ...
Health Affairs

A New Drug Could Change The HIV Prevention Landscape, But Only With A Fair Price Tag

In June, Gilead Sciences announced impressive early results from its PURPOSE 1 trial, which showed 100 percent efficacy of lenacapavir in preventing new HIV infections among cisgender women in ...
WLRN

HIV prevention drug hailed as a 'breakthrough' gets FDA approval

A drug with the potential to drastically curb the HIV epidemic just cleared its first regulatory hurdle. On Wednesday, the Food and Drug Administration approved lenacapavir for the prevention of HIV.
Hosted on MSN

Exclusive: List of Kenyan Hospitals That Will Offer Injectable HIV Vaccine for Free

Kenya, being the first nine countries globally selected to roll out Lenacapavir, a long-acting injectable HIV prevention drug, starting January 2026. The National AIDS and STI Control Programme ...
Reuters

GSK scraps plan to list HIV drugs business and shields dividend

LONDON (Reuters) - GlaxoSmithKline scrapped plans to float its HIV drug business on Wednesday and promised to pay a steady dividend for three years, setting out long-term growth targets after the ...
The Citizen

Anti-HIV injection lenacapavir added to Essential Medicines List

South Africa takes the lead in HIV prevention with a groundbreaking twice-a-year injection being added to the Essential Medicines List.